Heat Biologics - 3 Krebsmittel in der Pipeline!
Seite 154 von 176 Neuester Beitrag: 27.04.24 15:03 | ||||
Eröffnet am: | 17.09.13 23:22 | von: Balu4u | Anzahl Beiträge: | 5.38 |
Neuester Beitrag: | 27.04.24 15:03 | von: Highländer49 | Leser gesamt: | 1.182.116 |
Forum: | Hot-Stocks | Leser heute: | 175 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 152 | 153 | | 155 | 156 | ... 176 > |
HTBX Corporate Milestones
Below we list key milestones for Heat Biologics:
1 - Complete HS-110 Phase II NSCLC enrollment – 2Q:19
2 - HS-130 (ComPACT) IND filing and FDA Clearance – August 2019
3 - HS-110 interim data readout – November 2019
4 - HS-110 Phase II interim readout – 4Q:19
5 - PTX-35 IND clearance and first patient dosing – 2Q:20
6 - Various coronavirus vaccine milestones – 2Q:20
7 - ASCO Poster Presentation – May 29, 2020
8 - Discussion with potential partners – Ongoing
9 - Schedule End of Phase II Meeting with FDA – 2H:20
10 - Complete HS-130 Phase I trial – 4Q:20
11 - Develop Phase III / commercial manufacturing capacity for HS-110 2020
The University of Miami (HTBX' vaccine research partner) released a PR yesterday after the markets were closed!
They are on track to manufacture their COVID vaccine.
< 75M MC
-> Researchers gear up for preclinical testing of coronavirus vaccine
https://news.miami.edu/stories/2020/07/...of-coronavirus-vaccine.html